These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 598611

  • 21. Changes in obsessive/compulsive patients as measured by the Leyton Inventory before and after treatment with clomipramine.
    Allen JJ, Rack PH.
    Scott Med J; 1975; 20(1 SUPPL):41-4. PubMed ID: 1098144
    [Abstract] [Full Text] [Related]

  • 22. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P.
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [Abstract] [Full Text] [Related]

  • 23. Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
    Singh AN, Sexena B, Gent M.
    J Int Med Res; 1977 Apr; 5 Suppl 5():25-32. PubMed ID: 598603
    [Abstract] [Full Text] [Related]

  • 24. A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
    Gringras M, Luscombe DK, Jones RB, Beaumont G, Seldrup J, John V.
    J Int Med Res; 1977 Apr; 5(1 Suppl):119-24. PubMed ID: 863081
    [Abstract] [Full Text] [Related]

  • 25. Anafranil in obsessive compulsive neurosis.
    Wyndowe J, Solyom L, Ananth J.
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):611-7. PubMed ID: 812637
    [No Abstract] [Full Text] [Related]

  • 26. The management of phobic disorders using clomipramine (Anafranil).
    Waxman D.
    J Int Med Res; 1977 Nov; 5(1 Suppl):24-31. PubMed ID: 324831
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacokinetic studies in obsessional patients.
    Luscombe DK, Marks IM.
    J Int Med Res; 1977 Nov; 5 Suppl 5():91-6. PubMed ID: 598610
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA, Surman OS, Cassem NH, Zusky P, Anderson WH.
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clomipramine in obsessive-compulsive disorder: a review.
    Ananth J.
    Psychosomatics; 1983 Aug; 24(8):723-7. PubMed ID: 6356210
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.